Groowe Groowe / Newsroom / ABBV
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

ABBV News

ABBVIE INC.

Swarm Oncology appoints Bernhard Ehmer as Chairman

globenewswire.com
ABBV

Form 8-K

sec.gov
ABBV

ALLERGAN AESTHETICS HIGHLIGHTS MEDICAL WEIGHT LOSS (MWL) DATA AND THE CHANGING PROFILE OF PATIENTS

prnewswire.com
ABBV

LexisNexis Recognizes Visionary Companies From 18 Countries as “Top 100 Global Innovators” for 2026

globenewswire.com
IBM ADI AMAT AVGO CDNS CSCO DELL INTC LRCX MRVL MU NVDA QCOM SNPS TXN AMD LLY MRNA BMY GILD PFE JNJ ABBV AMGN BIIB REGN VRTX ADSK GOOG MSFT ORCL CRM ADPT ALGN BKR CTAS DDOG DXCM EXPE FIVN FTNT IDXX ILMN INTU ISRG JD KDP LULU MCHP MDLZ MELI MNST NFLX NOW NTES OKTA ON PANW PAYX PDD PEP PYPL ROKU SBUX SMCI SWKS TEAM TCOM TDS TER TGT TTEC TTWO TWLO ULTA VRSK WDC WEC XRAY ZBRA ZM ASML KLAC NXPI AMZN AAPL GOOGL META TSLA Z KHC CL PG COST WMT

Drug Discovery Leader Marcus Schindler Joins Cradle's Advisory Board

prnewswire.com
JNJ ABBV NVO

COMPUTEX 2026 Brings the Global AI Ecosystem to Taipei

prnewswire.com
MSI INTC TXN NVDA AMAT KLAC LRCX MU QCOM AMD GOOG MSFT AMZN IBM DELL HPQ VRTX ADI NXPI ON MCHP SNPS CDNS MRVL ADSK CTAS PAYX ADP CRM NOW PANW FTNT ZBRA HON GE ROK ETN GOOGL META NFLX DIS CMCSA T VZ TMUS CSCO ORCL SAP ACN DXC WDC SE SMCI DDOG MDB ZS CRWD SNOW PLTR UPST COIN PYPL AFRM SOFI HOOD UPWK FIVN RBLX EA TTWO U EXAS REGN BIIB GILD AMGN BMY PFE MRK JNJ ABBV LLY NVO AZN XOM CVX SHEL BABA JD PDD NTES BIDU VIPS EDU BEKE TAL BILI RLX XPEV NIO LI CPT LCID RIVN TSLA GM F STLA VWAGY HOG YETI GOOS LULU UA NKE ANF AEO URBN PVH RL TJX M BBY WMT COST TGT HD LOW SPG PLD AMT EQIX CCI DLR SBAC

AbbVie Announces Positive Topline Results from Phase 3 AFFIRM Study Evaluating SKYRIZI® (Risankizumab) Subcutaneous Induction in Patients with Crohn's Disease

prnewswire.com
ABBV

Continuous Manufacturing Market Trends and Global Forecasts, 2035 Featuring Key Players - AbbVie, Abzena, AGC Biologics, Boehringer Ingelheim, Corden Pharma, Glatt, Kaneka, Phlow, and Wuxi Biologics

globenewswire.com
ABBV

One in Three Rheumatologists View BMS’ Sotyktu as a Substantial Advance in Psoriatic Arthritis Ahead of March 6 FDA Decision, According to Spherix Global Insights Data

globenewswire.com
BMY PFE ABBV AMGN

ADARx Pharmaceuticals Presents Onvuzosiran Data Supporting Potential for Sustained Attack-Free Rates with Reduced Treatment Burden in Patients with HAE

globenewswire.com
ABBV